The KPNA3 Knockout HAP1 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population engineered to disrupt the KPNA3 gene in the human HAP1 cell line. This product provides a robust loss-of-function model for investigating the biological roles of importin subunit alpha-3 (KPNA3) in nuclear transport and downstream signaling pathways. The polyclonal nature of the cell population ensures a diverse range of genetic disruptions, offering a reproducible platform for functional genomics studies without the need for clonal isolation.
The HAP1 cell line is a near-haploid human cell line originally derived from the KBM-7 chronic myeloid leukemia line. Its near-haploid karyotype simplifies genetic manipulations and promotes efficient gene disruption, making it a widely adopted tool in high-throughput genetic screens and targeted knockout experiments. HAP1 cells retain many signaling pathways of somatic cells, enabling physiologically relevant analyses of gene function in a tractable system.
KPNA3 encodes importin alpha-3, an adaptor that recognizes classical nuclear localization signals (NLS) on cargo proteins. In the cytoplasm, it binds NLS-containing cargos and forms a trimeric complex with importin beta (KPNB1) to mediate docking at the nuclear pore complex. Translocation occurs through interactions with nucleoporins (e.g., NUP50, NUP62) and is driven by the Ran GTPase cycle. Nuclear RanGTP dissociates the complex, releasing the cargo. KPNA3 imports transcription factors such as NF-??B p65 (RELA), STAT1, and c-Jun, thereby regulating NF-??B and JAK-STAT signaling. It also facilitates nuclear entry of viral proteins. Upstream regulators include Ran GTPase, KPNB1, NLS cargo availability, and phosphorylation events. Representative pathway components: KPNA3, KPNB1, RAN, NUP50, NUP62, NFKBIA, RELA.
In HAP1 cells, knockout of KPNA3 provides a clean genetic background to dissect nuclear import dependency. The near-haploid nature of HAP1 ensures that gene disruption leads to a complete loss of function, enabling clear phenotypic readouts. Because KPNA3 is essential for the nuclear translocation of key transcription factors, its deletion is expected to impair NF-??B and STAT1 signaling, reducing their transcriptional activity. This can be leveraged to study the role of nuclear transport in cell proliferation, apoptosis, and responses to cytokines. Furthermore, many viruses exploit KPNA3 to enter the nucleus, making this knockout a valuable tool for virology research, potentially revealing host dependency factors.
Researchers can use this knockout model in diverse assays. Immunofluorescence and subcellular fractionation reveal cargo mislocalization; western blotting confirms protein levels. NF-??B reporter assays and RT-qPCR quantify signaling outputs, while RNA-seq captures transcriptome changes. Co-immunoprecipitation probes altered interactions, and flow cytometry measures pathway activation. Applications include functional genomics, drug target discovery (screening nuclear import inhibitors), viral infection studies, and cancer biology examining transcription factor localization. For further information, please contact Ascent Research.
